Roman Yelensky - Mar 8, 2021 Form 4/A - Amendment Insider Report for Gritstone bio, Inc. (GRTS)

Role
Executive Vice President and Chief Technology Officer
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Roman Yelensky
Stock symbol
GRTS
Transactions as of
Mar 8, 2021
Transactions value $
$38,500
Form type
4/A - Amendment
Date filed
11/19/2021, 05:20 PM
Date Of Original Report
Apr 16, 2021
Previous filing
Nov 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Options Exercise $38.5K +50.7K +27.58% $0.76 235K Mar 8, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTS Stock Option (Right to Buy) Options Exercise $0 -50.7K -100% $0.00* 0 Mar 8, 2021 Common Stock 50.7K $0.76 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Roman Yelensky is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes 27,400 RSUs which are subject to vesting.
F2 Fully exercisable.

Remarks:

Executive Vice President and Chief Technology Officer